Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]
ReiThera will begin commercial production in 2026, a milestone the [...]
Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]
ReiThera will begin commercial production in 2026, a milestone the [...]